Innovating Works

UNIKIN

Desconocido
MPOX-PROBE: Strengthening epidemiological genomic and community surveillance of Mpox virus MPXV at the Congo... The spread of Mpox virus (MPXV) in Sub-Saharan Africa, specifically Democratic Republic of Congo (DRC) and Republic of Congo (RoC) presents...
2024-09-27 - 2026-09-30 | Financiado
PregInPoxVac: MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3 OPEN LABEL RANDOMISED VACCINE TRIAL OF... Mpox can cause severe complications in vulnerable groups such as pregnant women and children, necessitating targeted public health intervent...
2024-08-26 - 2027-07-31 | Financiado
ODIN-MPox: Implementing wastewater and environmental surveillance for Mpox in Sub Saharan Africa UNIVERSITE DE KINSHASA participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox, a re-emerging viral zoonotic disease, has recently posed significant public health challenges in sub-Saharan Africa, particularly in t...
2024-08-07 - 2026-07-31 | Financiado
SEMA ReACT: SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote... UNIVERSITE DE KINSHASA participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Annually, almost 500,000 children under 5 years die from malaria in Africa. Timely access to effective antimalarial therapies is life saving...
2023-03-07 - 2027-03-31 | Financiado
EBOVAC3: Bringing a prophylactic Ebola vaccine to licensure UNIVERSITE DE KINSHASA participó en un H2020: H2020-JTI-IMI2-2015-08-single-stage The overall aim of EBOVAC3 is to support an essential part of remaining clinical and manufacturing activities required for licensure in the...
2018-06-15 - 2024-09-30 | Financiado
MAFE: Migration between Africa and Europe UNIVERSITE DE KINSHASA participó en un FP7: African migration has become a major concern for European policy makers. New policy measures are under development, but they rely on a poor...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.